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May 22, 2012:1915–8When looking carefully at the Bland-Altman plot (Fig. 10B in
Sen et al. [1]) we notice that: 1) the difference between FFR and
iFR exceeds the clinically tolerable threshold of 5% in more than
half of the measurements; and 2) the agreement between the 2
methods is better for very high, nonsignificant FFR values (0.85)
than for values that indicate hemodynamically significant stenoses.
Therefore, it would be very interesting to see in what percentage of
individual cases disagreement between iFR and FFR would result
in reclassification of stenosis from nonsignificant to significant and
vice versa.
In summary: the investigators should be congratulated for an
excellent innovation and a very elegant study. However, we feel
that based on the data presented, the satisfactory statistical
correlation may not translate into clinical usefulness.
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Instantaneous Wave-Free Ratio
or Fractional Flow Reserve
Without Hyperemia
Novelty or Nonsense?
We read the paper by Sen et al. (1) with great interest. We have a
number of concerns regarding the proposed index, instantaneous
wave-free ratio (iFR). First, the validity of iFR depends on the
assumption that minimum resting myocardial resistance during
diastole is equivalent to the mean resistance during maximum
hyperemia. We believe that this assumption is not correct. Nu-
merous experimental studies performed over the last 4 decades
using true volumetric flow measurement and calculating absolute
resistance have provided incontrovertible proof that blood flow at
rest in a normal coronary artery is very low during systole (because
of the high resistance) and occurs primarily during diastole. During
maximum hyperemia, flow increases during both phases of the
cardiac cycle, but much more so during diastole. Because blood
pressure remains either unchanged or decreases by approximately
10% to 15% (depending on the hyperemic stimulus used), both
systolic and diastolic resistance will fall accordingly. Consequently,
the minimal diastolic resistance at rest (regardless of whether the
entire diastole or the so-called wave-free period is taken) generallyis 50% to 100% higher than the average resistance over the
complete heart cycle during hyperemia (2,3).
For example, in a normal left anterior descending coronary
artery in a human at rest, diastolic flow is approximately 75
ml/min. During maximal hyperemia, flow during the complete
heart cycle increases to 350 ml/min with still 75% to 80% of blood
flow during diastole. Because there are only small changes in blood
pressure or heart rate, the minimum diastolic resistance at rest, is
more than twice as great as the average hyperemic resistance. Close
examination of Figure 2 in the paper by Sen et al. (1) reveals that
the lowest value of resistance during any moment of the heart cycle
at rest is approximately 40% higher than the average resistance at
hyperemia.
These differences may explain why the correlation between iFR
and FFR as presented in Figure 8 of the paper by Sen et al. (1) is
weak. For a given FFR value of 0.60, iFR values range between 0.4
and 0.9. This is obscured in the Bland-Altmann diagram by the
extreme compression of the vertical axis. Certainly, in a mild
stenosis with minimal gradient during rest or hyperemia, as a
matter of fact, all indexes are equal, and the correlation between
iFR and fractional flow reserve (FFR) is excellent. The same is true
for severe stenosis where vasodilator reserve is exhausted and no
additional changes in resistance can occur. However, in the
clinically relevant range of FFR between 0.60 and 0.90, the
correlation between iFR and FFR is rather poor. In addition,
taking a threshold value of 0.83 is based on retrospective receiver-
operating characteristic curve analysis and reflects the systematic
overestimation of true FFR by iFR, rather than, as suggested, any
issue related to physiological reproducibility.
Second, it is unclear why the wave intensity analysis theory is
introduced to justify the use of iFR. In practice, iFR is calculated
simply as the ratio of mean distal coronary pressure to mean aortic
pressure during a predefined fixed part of diastole. There does not
seem to be any instantaneous component to the index. We do not
understand why the differential equation in the paper by Sen
et al. (1) is necessary to define iFR.
Finally, we have calculated iFR in a large number of FFR
tracings with appropriate resting and hyperemic pressure record-
ings obtained in our laboratories during the last few months (n 
555). We have found a weak correlation with a diagnostic accuracy
of 69% for all data and 60% in the relevant FFR range between
0.60 and 0.90. Moreover, even larger differences were found
between iFR at rest and iFR at hyperemia, despite the fact that by
definition, iFR should be independent of hyperemia. This is
particularly important because true resting conditions are difficult
to obtain during cardiac catheterization (4,5).
Have we overlooked something or done anything wrong? More
specifically, is there a correction factor used by the authors in their
algorithm not reported in the article? We are in favor of introduc-
ing new mechanisms for facilitating the application of coronary
physiology to guide procedures in the cardiac catheterization
laboratory. However, we urge caution before applying a new index
routinely in clinical practice until it can be understood adequately
and validated prospectively in larger and more diverse groups of
patients.
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Reply
We sincerely thank these correspondents for their keen interest in
our work (1). Instantaneous wave-free ratio (iFR) would not have
been possible without fractional flow reserve (FFR). The authors
are strong supporters and regular users of pressure-derived indices
of stenosis severity in their clinical practice, and they acknowledge
the great impact that FFR has had on patient management. More
than an independent index of stenosis severity, iFR constitutes a
scientific attempt to get FFR-like measurements with further
simplification of the technique, with the aim of facilitating
adoption of physiology in the catheter laboratory and thus improv-
ing patient management. We are aware that FFR constitutes the
current paradigm of invasive stenosis assessment, and therefore, we
welcome the healthy criticisms and the hint of skepticism implicit
in the 3 letters sent to the Editor, occasionally with some déjà vu
of the initial reactions witnessed during the introduction of FFR.
Dr. Rudzinski and colleagues raise several excellent points. iFR
and FFR do agree best at higher values. But where they disagree,
historic teaching would be that FFR—in which resistance is
aggressively minimized—should always have the lower pressure
ratio. Actual observations are opposite to this. It is with relief thatwe find the mechanism for this has been extensively established in
the physiology literature. Intense pharmacological vasodilator
stimuli can disrupt natural regulatory mechanisms beyond their
homeostatic range, and lead to a paradoxical increase in microcir-
culatory resistance by reducing coronary perfusion pressure (2).
While previously obvious only in pressure flow studies, it can now
be seen in the elevation of the Pd/Pa ratio by adenosine in FFR,
because for the first time stable wave-free Pd/Pa can be measured
(iFR) without pharmacological interference by adenosine. These
paradoxical disturbances in resistance by adenosine are obvious in
the severe range, but cannot be assumed to be absent in the rest of
the wide spectrum. The Bland-Altman plot may have its upward
tilt to the left explained by this.
The scatter of the Bland-Altman plot has little scope to be
much narrower because, just as iFR comes with its intrinsic
variability, FFR also has intrinsic variability, most elegantly de-
scribed in the DEFER study, which showed that, within 10 min in
the same patient in the same expert hands, an FFR of 0.86 initially
could jump between 0.70 and 0.90 on repeated measure (3). For
this reason, neither iFR, nor FFR, nor any other measure, could
ever match FFR perfectly. Despite this, we are encouraged by the
fact that the scatter of our plot was much narrower than that in the
Bland-Altman plot, demonstrating the widely accepted excellent
relationship between FFR to positron emission tomography (4).
Contrary to the opinion of Dr. Finet and colleagues, we found
wave intensity analysis (WIA) a very useful tool to demonstrate in
a scientific and objective way how to overcome the limitations
imposed by using time-averaged pressures for FFR calculation. As
a matter of fact, WIA revealed the limits of the nice metaphor used
by Dr. Finet and colleagues depicting adenosine-FFR as a wind
tunnel, showing that, contrary to the constant laminar flow used in
a wind tunnel, constant variations (“bumps”) occur in the coronary
arteries as a result of waves generated from the aorta and the
microcirculation over the cardiac cycle, with the exception of a
short wave-free period within diastole that best fulfils the theoret-
ical requirements of FFR. Once this wave-free period was identi-
fied, we compared the values of coronary resistance with those
obtained with time-averaged pressures in FFR. The documented
similarity of resistance values shown in Figure 5 of our paper (1),
and not the absence of waves as such as suggested by Finet and
coworkers, stands as the cornerstone of iFR. Although seldom
found, FFR values around 0.2 can be found in clinical practice and
in some of the foundational papers of FFR (3,5).
The statement by Dr. Pijls and colleagues that “the validity of
iFR depends on the assumption that minimum resting myocardial
resistance during diastole is equivalent to the mean resistance
during maximum hyperemia” is incorrect. A more correct proposal
would be that the validity of iFR depends on the demonstration
that myocardial resistance during a specific part of diastole (iFR) is
similar in stability and magnitude to that calculated from whole
cycle averaged measurements during hyperemia (FFR). In our
paper, we highlighted that the reduction in myocardial resistance
in response to adenosine administration is largely due to a reduction
in its systolic component, a key issue to understand why the resis-
tances underlying FFR and iFR calculation are similar, but we did not
propose that diastolic myocardial resistance remains completely un-
changed during adenosine-induced hyperemia. However, if excessive
resistance explained the difference between iFR and FFR, the numer-
ical disagreement between them would be related to the difference in
resistance between the 2 states. But it is not (Fig. 1).
